33972291|t|Templated alpha-Synuclein Inclusion Formation Is Independent of Endogenous Tau.
33972291|a|Synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are characterized by neuronal intracellular inclusions of alpha-synuclein. PD dementia (PDD) and DLB are collectively the second most common cause of neurodegenerative dementia. In addition to associated inclusions, Lewy body diseases (LBDs) have dopaminergic neurodegeneration, motor defects and cognitive changes. The microtubule-associated protein tau has been implicated in LBDs, but the exact role of the protein and how it influences formation of alpha-synuclein inclusions is unknown. Reducing endogenous tau levels is protective in multiple models of Alzheimer's disease (AD), tauopathies, and in some transgenic synucleinopathy mouse models. Recombinant alpha-synuclein and tau proteins interact in vitro Here, we show tau and alpha-synuclein colocalize at excitatory presynaptic terminals. However, tau heterozygous and tau knock-out mice do not show a reduction in fibril-induced alpha-synuclein inclusions formation in primary cortical neurons, or after intrastriatal injections of fibrils at 1.5 month or six months later. At six months following intrastriatal injections, wild-type, tau heterozygous and tau knock-out mice showed a 50% reduction in dopamine neurons in the substantia nigra pars compacta (SNc) compared with mice injected with alpha-synuclein monomer, but there were no statistically significant differences across genotypes. These data suggest the role of tau in the pathogenesis of LBDs is distinct from AD, and Lewy pathology formation may be independent of endogenous tau.
33972291	10	25	alpha-Synuclein	Gene	20617
33972291	80	97	Synucleinopathies	Disease	MESH:D000080874
33972291	108	127	Parkinson's disease	Disease	MESH:D010300
33972291	129	131	PD	Disease	MESH:D010300
33972291	137	162	dementia with Lewy bodies	Disease	MESH:D020961
33972291	164	167	DLB	Disease	MESH:D020961
33972291	227	242	alpha-synuclein	Gene	20617
33972291	244	255	PD dementia	Disease	MESH:D010300
33972291	257	260	PDD	Disease	MESH:D010300
33972291	266	269	DLB	Disease	MESH:D020961
33972291	319	345	neurodegenerative dementia	Disease	MESH:D019636
33972291	385	403	Lewy body diseases	Disease	MESH:D020961
33972291	405	409	LBDs	Disease	MESH:D020961
33972291	429	446	neurodegeneration	Disease	MESH:D019636
33972291	448	461	motor defects	Disease	MESH:D000068079
33972291	466	475	cognitive	Disease	MESH:D003072
33972291	489	523	microtubule-associated protein tau	Gene	17762
33972291	547	551	LBDs	Disease	MESH:D020961
33972291	622	637	alpha-synuclein	Gene	20617
33972291	728	747	Alzheimer's disease	Disease	MESH:D000544
33972291	749	751	AD	Disease	MESH:D000544
33972291	754	765	tauopathies	Disease	MESH:D024801
33972291	790	805	synucleinopathy	Disease	MESH:D000080874
33972291	806	811	mouse	Species	10090
33972291	832	847	alpha-synuclein	Gene	20617
33972291	905	920	alpha-synuclein	Gene	20617
33972291	1013	1017	mice	Species	10090
33972291	1060	1075	alpha-synuclein	Gene	20617
33972291	1301	1305	mice	Species	10090
33972291	1332	1340	dopamine	Chemical	MESH:D004298
33972291	1407	1411	mice	Species	10090
33972291	1426	1441	alpha-synuclein	Gene	20617
33972291	1583	1587	LBDs	Disease	MESH:D020961
33972291	1605	1607	AD	Disease	MESH:D000544
33972291	1613	1627	Lewy pathology	Disease	MESH:D005598
33972291	Association	MESH:D000080874	20617
33972291	Association	MESH:D020961	17762
33972291	Association	MESH:D010300	20617
33972291	Association	MESH:D004298	20617
33972291	Association	MESH:D020961	20617

